These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2911012)

  • 1. Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten.
    Sharon J; Gefter ML; Wysocki LJ; Margolies MN
    J Immunol; 1989 Jan; 142(2):596-601. PubMed ID: 2911012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of H chain-associated idiotopes of anti-p-azophenylarsonate monoclonal antibodies.
    Parhami-Seren B; Sharon J; Margolies MN
    J Immunol; 1990 Jun; 144(11):4426-33. PubMed ID: 2111347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustered H chain somatic mutations shared by anti-p-azophenylarsonate antibodies confer enhanced affinity and ablate the cross-reactive idiotype.
    Parhami-Seren B; Wysocki LJ; Margolies MN; Sharon J
    J Immunol; 1990 Oct; 145(7):2340-6. PubMed ID: 2118935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino acid residues at the VH-D-JH junctions affect the affinity of anti-p-azophenylarsonate antibodies.
    Parhami-Seren B; Wysocki L; Margolies MN
    J Immunol; 1989 Dec; 143(12):4090-7. PubMed ID: 2512349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of two idiotypic subfamilies of murine anti-p-azobenzenearsonate antibodies.
    Robbins PF; Nisonoff A
    J Immunol; 1987 Dec; 139(11):3868-77. PubMed ID: 3119722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservation of binding site geometry among p-azophenylarsonate-specific antibodies.
    Parhami-Seren B; Kussie PH; Strong RK; Margolies MN
    J Immunol; 1993 Mar; 150(5):1829-37. PubMed ID: 8436818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single engineered amino acid substitution changes antibody fine specificity.
    Kussie PH; Parhami-Seren B; Wysocki LJ; Margolies MN
    J Immunol; 1994 Jan; 152(1):146-52. PubMed ID: 8254187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies.
    Parhami-Seren B; Margolies MN
    J Immunol; 1996 Sep; 157(5):2066-72. PubMed ID: 8757328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural correlates of high antibody affinity: three engineered amino acid substitutions can increase the affinity of an anti-p-azophenylarsonate antibody 200-fold.
    Sharon J
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4814-7. PubMed ID: 2352950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete heavy and light chain variable region sequence of anti-arsonate monoclonal antibodies from BALB/c and A/J mice sharing the 36-60 idiotype are highly homologous.
    Juszczak E; Near RI; Gefter ML; Margolies MN
    J Immunol; 1984 Nov; 133(5):2603-9. PubMed ID: 6207237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and fluorescence studies of affinity maturation in related antibodies.
    Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
    Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of azophenylarsonate-specific repertoire expression. II. Fine specificity and isotype heterogeneity of anti-arsonate antibodies.
    Sigal NH
    J Immunol; 1983 Oct; 131(4):1889-94. PubMed ID: 6194218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinational diversity within variable regions bearing the predominant anti-p-azophenylarsonate idiotype of strain A mice.
    Wysocki LJ; Margolies MN; Huang B; Nemazee DA; Wechsler DS; Sato VL; Smith JA; Gefter ML
    J Immunol; 1985 Apr; 134(4):2740-7. PubMed ID: 2982953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural studies on induced antibodies with defined idiotypic specificities. V. The complete amino acid sequence of the light chain variable regions of anti-p-azophenylarsonate antibodies from A/J mice bearing a cross-reactive idiotype.
    Capra JD; Tung AS; Nisonoff A
    J Immunol; 1977 Sep; 119(3):993-9. PubMed ID: 70482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of JH4 joining segment gene by an anti-arsonate antibody that bears the major A-strain cross-reactive idiotype but displays diminished antigen binding.
    Slaughter CA; Jeske DJ; Kuziel WA; Milner EC; Capra JD
    J Immunol; 1984 Jun; 132(6):3164-71. PubMed ID: 6427333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of idiotopic suppression induced by anti-cross-reactive idiotype monoclonal antibody in the anti-p-azophenylarsonate antibody response.
    Hiernaux JR; Marvel J; Meyers P; Moser M; Leo O; Slaoui M; Urbain J
    J Immunol; 1986 Mar; 136(6):1960-7. PubMed ID: 3950406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin idiotype and anti-anti-idiotype utilize the same variable region genes irrespective of antigen specificity.
    Margolies MN; Wysocki LJ; Sato VL
    J Immunol; 1983 Feb; 130(2):515-7. PubMed ID: 6184395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular and biochemical characterization of mutant monoclonal antibodies with increased antigen binding.
    French DL; Pollock RR; Aguila HL; Scharff MD
    J Immunol; 1991 Mar; 146(6):2010-6. PubMed ID: 1672339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of various D elements with a single-immunoglobulin VH gene segment: influence on the expression of a major cross-reactive idiotype.
    Gridley T; Margolies MN; Gefter ML
    J Immunol; 1985 Feb; 134(2):1236-44. PubMed ID: 3917472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of antibody affinity by an engineered amino acid substitution.
    Wong YW; Kussie PH; Parhami-Seren B; Margolies MN
    J Immunol; 1995 Apr; 154(7):3351-8. PubMed ID: 7897218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.